The trend of pooled sero-prevalence of HIV among blood donors in Ethiopia (1989–2018) | ||||||||
---|---|---|---|---|---|---|---|---|
Study year (based on mid-term year) | Number of included studies | Total No. of HIV sero-reactive case | Total No. of Population | Pooled prevalence of HIV %(95% CI) | Heterogeneity | Meta-regression (effect of year on HIV prevalence) | ||
I2 % | P-value | Coefficient(95% CI) | P-value | |||||
Before 2000 | 5 | 1994 | 20,103 | 8.84 (5.96, 17.73) | 97.7 | < 0.001 | − 0.089 (− 0.133, − 0.045) | < 0.001 |
2000–2004 | 3 | 95 | 4313 | 3.27 (1.02, 5.53) | 88.5 | < 0.001 | ||
2005–2009 | 3 | 296 | 9291 | 4.55 (1.67, 7.44) | 98.6 | < 0.001 | ||
2010–2014 | 11 | 4197 | 251,971 | 1.70 (1.14, 2.26) | 99.3 | < 0.001 | ||
2015–2018 | 12 | 546 | 69,348 | 1.20 (0.87, 1.53) | 94.9 | < 0.001 | ||
Total | 34 | 7128 | 355,026 | 2.83 (2.43, 3.23) | 99.2 | < 0.001 |
The trend of pooled sero-prevalence of HBV among blood donors in Ethiopia (1986–2018) | ||||||||
---|---|---|---|---|---|---|---|---|
Study year (based on mid-term year | Number of included studies | Total No. of HBV sero-reactive case | Total No. of Population | Pooled prevalence of HBV % (95% CI) | Heterogeneity | Meta-regression (effect of year on HBV prevalence) | ||
I2 % | P-value | Coefficient (95% CI) | P-value | |||||
Before 2000 | 3 | 173 | 1415 | 12.03 (9.72, 14.34) | 46.2 | 0.156 | − 0.029 (− 0.078, 0.02) | 0.25 |
2000–2004 | 2 | 86 | 1200 | 7.10 (5.14, 9.05) | 44.6 | 0.179 | ||
2005–2009 | 5 | 645 | 14,985 | 6.72 (4.03, 9.40) | 98.7 | < 0.001 | ||
2010–2014 | 13 | 14,652 | 310,478 | 4.76 (4.05, 5.47) | 98.6 | < 0.001 | ||
2015–2018 | 13 | 2240 | 63,261 | 4.30 (3.35, 5.24) | 96.8 | < 0.001 | ||
Total | 36 | 17,796 | 391,339 | 5.20 (4.64, 5.77) | 98.4 | < 0.001 |
The trend of pooled sero-prevalence of HIV among blood donors in Ethiopia (1991–2018) | ||||||||
---|---|---|---|---|---|---|---|---|
Study year (based on mid-term year | Number of included studies | Total No. of HCV sero-reactive case | Total No. of Population | Pooled prevalence of HCV % (95% CI) | Heterogeneity | Meta-regression (effect of year on HCV prevalence) | ||
I2 % | P-value | Coefficient (95% CI) | P-value | |||||
Before 2000 | 2 | 10 | 720 | 1.40 (0.54, 2.26) | 0.0 | 1 | − 0.041 (− 0.093, 0.01) | 0.114 |
2000–2004 | 2 | 45 | 1200 | 3.69 (− 0.36, 7.74) | 93.0 | < 0.001 | ||
2005–2009 | 4 | 137 | 10,136 | 1.86 (0.81, 2.90) | 95.2 | < 0.001 | ||
2010–2014 | 12 | 3182 | 306,321 | 0.71 (0.41, 1.00) | 98.7 | < 0.001 | ||
2015–2018 | 11 | 453 | 62,499 | 0.83 (0.55, 1.11) | 91.2 | < 0.001 | ||
Total | 31 | 3827 | 380,876 | 0.93 (0.73, 1.13) | 97.3 | < 0.001 |
The trend of pooled sero-prevalence of Syphilis among blood donors in Ethiopia (1989–2018) | ||||||||
---|---|---|---|---|---|---|---|---|
Study year (based on mid-term year | Number of included studies | Total No. of Syphilis sero-reactive case | Total No. of Population | Pooled prevalence of Syphilis % (95% CI) | Heterogeneity | Meta-regression (effect of year on Syphilis prevalence) | ||
I2 | P-value | Coefficient (95% CI) | P-value | |||||
Before 2000 | 3 | 1334 | 23,893 | 8.39 (3.71, 13.08) | 98.8% |  < 0.001 | − 0.085 (− 0.156, − 0.015) | 0.021 |
2000–2004 | – | – | – | – | – | – | ||
2005–2009 | 4 | 113 | 13,446 | 0.83 (0.06, 1.59) | 96.2% |  < 0.001 | ||
2010–2014 | 8 | 413 | 227,743 | 0.50 (0.29, 0.71) | 97.3% |  < 0.001 | ||
2015–2018 | 8 | 614 | 55,648 | 1.04 (0.67, 1.40) | 90.8% |  < 0.001 | ||
Total | 23 | 2474 | 320,730 | 1.50 (1.20, 1.80) | 99.0% |  < 0.001 |